REQUEST A DEMO
Total
USD $0.00
Search more companies

Nbiomec S.A.S. (Ecuador)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Health and Personal Care Stores
Full name: Nbiomec S.A.S. Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Nbiomec S.A.S. is a company in Ecuador, with a head office in Guayaquil. It operates in the Pharmacies and Drug Stores industry. The company was established on September 03, 2021. 4 (2023) employees currently work for Nbiomec S.A.S.. The latest financial highlights indicate a net sales revenue increase of 334.98% in 2023. Its total assets grew by 1758.28% over the same period. The net profit margin of Nbiomec S.A.S. decreased by 17.72% in 2023.

Headquarters
Calle 7mo Callejon 6, 1 Bldg. , Floor 1
Guayaquil; Guayas;

Contact Details: Purchase the Nbiomec S.A.S. report to view the information.

Website: http://www.nbiomec.com

Basic Information
Total Employees:
Purchase the Nbiomec S.A.S. report to view the information.
Outstanding Shares:
Purchase the Nbiomec S.A.S. report to view the information.
Registered Capital:
Purchase the Nbiomec S.A.S. report to view the information.
Incorporation Date:
September 03, 2021
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Nbiomec S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
334.98%
Total operating revenue
334.98%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
-5.6%
Total assets
1758.28%
Total equity
36.91%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-17.72%
Return on Equity (ROE)
-12.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?